DRUG · COUNSELLING NOTES
Gemtuzumab Ozogamicin
MYLOTARG
Updated
New prescription
indication: _____. IV in clinic; report fever, bleeding, jaundice; contraception; warned on allergies; serious/common AEs: liver VOD, infection, bleeding; non-pharm: infection precautions
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; IV in clinic; report fever, bleeding, jaundice; contraception; warned on allergies; serious/common AEs: liver VOD, infection, bleeding; non-pharm: infection precautions